260 related articles for article (PubMed ID: 32877730)
1. The uses of resveratrol for neurological diseases treatment and insights for nanotechnology based-drug delivery systems.
Fonseca-Santos B; Chorilli M
Int J Pharm; 2020 Nov; 589():119832. PubMed ID: 32877730
[TBL] [Abstract][Full Text] [Related]
2. Alzheimer's Disease and its Related Dementia Types: A Review on Their Management
Siafaka PI; Mutlu G; Okur NÜ
Curr Alzheimer Res; 2020; 17(14):1239-1261. PubMed ID: 33602090
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol Brain Delivery for Neurological Disorders Prevention and Treatment.
Andrade S; Ramalho MJ; Pereira MDC; Loureiro JA
Front Pharmacol; 2018; 9():1261. PubMed ID: 30524273
[TBL] [Abstract][Full Text] [Related]
4. Recent progress of drug nanoformulations targeting to brain.
Khan AR; Yang X; Fu M; Zhai G
J Control Release; 2018 Dec; 291():37-64. PubMed ID: 30308256
[TBL] [Abstract][Full Text] [Related]
5. Nanotechnology for enhanced nose-to-brain drug delivery in treating neurological diseases.
Huang Q; Chen Y; Zhang W; Xia X; Li H; Qin M; Gao H
J Control Release; 2024 Feb; 366():519-534. PubMed ID: 38182059
[TBL] [Abstract][Full Text] [Related]
6. Brain targeting based nanocarriers loaded with resveratrol in Alzheimer's disease: A review.
Jalili C; Kiani A; Gholami M; Bahrehmand F; Fakhri S; Kakehbaraei S; Kakebaraei S
IET Nanobiotechnol; 2023 May; 17(3):154-170. PubMed ID: 36949020
[TBL] [Abstract][Full Text] [Related]
7. Nanocarrier Mediated Intranasal Drug Delivery Systems for the Management of Parkinsonism: A Review.
Kapoor A; Hafeez A; Kushwaha P
Curr Drug Deliv; 2024; 21(5):709-725. PubMed ID: 37365787
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticlized System: Promising Approach for the Management of Alzheimer's Disease through Intranasal Delivery.
Bahadur S; Sachan N; Harwansh RK; Deshmukh R
Curr Pharm Des; 2020; 26(12):1331-1344. PubMed ID: 32160843
[TBL] [Abstract][Full Text] [Related]
9. Intranasal delivery: circumventing the iron curtain to treat neurological disorders.
Jiang Y; Li Y; Liu X
Expert Opin Drug Deliv; 2015; 12(11):1717-25. PubMed ID: 26206202
[TBL] [Abstract][Full Text] [Related]
10. Drug delivery across the blood-brain barrier: recent advances in the use of nanocarriers.
Mulvihill JJ; Cunnane EM; Ross AM; Duskey JT; Tosi G; Grabrucker AM
Nanomedicine (Lond); 2020 Jan; 15(2):205-214. PubMed ID: 31916480
[TBL] [Abstract][Full Text] [Related]
11. Fabrication of an ionic-sensitive in situ gel loaded with resveratrol nanosuspensions intended for direct nose-to-brain delivery.
Hao J; Zhao J; Zhang S; Tong T; Zhuang Q; Jin K; Chen W; Tang H
Colloids Surf B Biointerfaces; 2016 Nov; 147():376-386. PubMed ID: 27566226
[TBL] [Abstract][Full Text] [Related]
12. Intranasal Delivery of Nanoformulations: A Potential Way of Treatment for Neurological Disorders.
Islam SU; Shehzad A; Ahmed MB; Lee YS
Molecules; 2020 Apr; 25(8):. PubMed ID: 32326318
[TBL] [Abstract][Full Text] [Related]
13. Applications of nanotechnology in drug delivery to the central nervous system.
Saeedi M; Eslamifar M; Khezri K; Dizaj SM
Biomed Pharmacother; 2019 Mar; 111():666-675. PubMed ID: 30611991
[TBL] [Abstract][Full Text] [Related]
14. Intranasal Lipid Particulate Drug Delivery Systems: An Update on Clinical Challenges and Biodistribution Studies of Cerebroactive Drugs in Alzheimer's disease.
Arora D; Bhatt S; Kumar M; Vattikonda HDC; Taneja Y; Jain V; Joshi V; Gali CC
Curr Pharm Des; 2020; 26(27):3281-3299. PubMed ID: 32228421
[TBL] [Abstract][Full Text] [Related]
15. Current insights on lipid nanocarrier-assisted drug delivery in the treatment of neurodegenerative diseases.
Teixeira MI; Lopes CM; Amaral MH; Costa PC
Eur J Pharm Biopharm; 2020 Apr; 149():192-217. PubMed ID: 31982574
[TBL] [Abstract][Full Text] [Related]
16. Nanosized Transferosome-Based Intranasal In Situ Gel for Brain Targeting of Resveratrol: Formulation, Optimization, In Vitro Evaluation, and In Vivo Pharmacokinetic Study.
Salem HF; Kharshoum RM; Abou-Taleb HA; Naguib DM
AAPS PharmSciTech; 2019 May; 20(5):181. PubMed ID: 31049748
[TBL] [Abstract][Full Text] [Related]
17. Updated Progress of Nanocarrier-Based Intranasal Drug Delivery Systems for Treatment of Brain Diseases.
Fan Y; Chen M; Zhang J; Maincent P; Xia X; Wu W
Crit Rev Ther Drug Carrier Syst; 2018; 35(5):433-467. PubMed ID: 30317945
[TBL] [Abstract][Full Text] [Related]
18. Emerging Use of Nanotechnology in the Treatment of Neurological Disorders.
Chhabra R; Tosi G; Grabrucker AM
Curr Pharm Des; 2015; 21(22):3111-30. PubMed ID: 26027574
[TBL] [Abstract][Full Text] [Related]
19. Nanotechnology-based formulations for resveratrol delivery: Effects on resveratrol in vivo bioavailability and bioactivity.
Santos AC; Pereira I; Pereira-Silva M; Ferreira L; Caldas M; Collado-González M; Magalhães M; Figueiras A; Ribeiro AJ; Veiga F
Colloids Surf B Biointerfaces; 2019 Aug; 180():127-140. PubMed ID: 31035056
[TBL] [Abstract][Full Text] [Related]
20. Nasal-nanotechnology: revolution for efficient therapeutics delivery.
Kumar A; Pandey AN; Jain SK
Drug Deliv; 2016; 23(3):681-93. PubMed ID: 24901207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]